TreeFrog opens stem cell manufacturing facility
The startup completes work on facility to produce stem cell therapies in-house.
The startup completes work on facility to produce stem cell therapies in-house.
The CDMO announces the lease of its third site in the US, the latest being focused on clinical supply.
The cell therapy can now be produced for 4,000 patients per year in Europe.